Early effects such as appetite reduction may appear within weeks, while significant weight loss and metabolic changes typically develop over several months
doi:10.1056/NEJMoa2206038
Among adults ages 65 and over, 8% say they have taken a GLP-1 medication for a chronic condition, while just 1% say they have taken these drugs only to lose weight, which may be a reflection of Medicares lack of coverage for prescription drugs used for weight loss
Anyone handling retatrutide whether as a clinical trial participant or healthcare professional must follow the Investigational Medicinal Product (IMP) label, the trial manual, or the dispensing pharmacist's instructions, and must not use the product beyond its labelled expiry date
Timelines vary, but many patients begin to notice changes in 24 weeks, such as reduced soreness, better range of motion, or quicker recovery after activity
If your dosage protocols are based on a specific purity level and your actual product deviates significantly from that level, every data point becomes unreliable
